• 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
Milprazon 12,5 mg/125 mg tabletės nuo kirminų ne mažiau kaip 5 kg sveriantiems šunims
Milprazon 12,5 mg/125 mg tabletės nuo kirminų ne mažiau kaip 5 kg sveriantiems šunims

Milprazon 12,5 mg/125 mg tabletės nuo kirminų ne mažiau kaip 5 kg sveriantiems šunims

Prekės kodas: M52559 Gamintojas: KRKA

Milprazon 12,5 mg/125 mg tabletės nuo kirminų šunims, sveriantiems ne mažiau nei 5 kg.

4,19 €
Kaina fizinėse parduotuvėse gali skirtis.
Turime sandėlyje. Prekę išsiųsime artimiausią darbo dieną!

Kiekis

Minimalus prekės užsakymo kiekis yra 2 vnt.

Milprazon 12,5 mg/125 mg tabletės nuo kirminų ne mažiau kaip 5 kg sveriantiems šunims

Milprazon 12,5 mg/125 mg tabletės nuo kirminų ne mažiau kaip 5 kg sveriantiems šunims

4,19 €

Pristatymas

Venipak kurjeris

Patogus prekių pristatymas su kurjeriu 1-2 d.d.

Pristatysime į namus Antradienį, Kovo 4 d.
Venipak paštomatai

Atsiimkite jums patogiame paštomate per 1-2 d.d.

Atsiimkite paštomate Antradienį, Kovo 4 d.
Atsiimti parduotuvėje

Atsiimkite jums patogioje parduotuvėje

Atsiimkite parduotuvėje Pirmadienį, Kovo 3 d.
Express kurjeris. Greitas pristatymas Vilniaus mieste.

Užsakyk šiandien ir gauk užsakymą rytoj (darbo dienomis)

Pristatysime į namus Pirmadienį, Kovo 3 d.
Omniva paštomatai

Atsiimkite jums patogiame paštomate per 1-2 d.d.

Atsiimkite paštomate Antradienį, Kovo 4 d.
Omniva kurjeris

Patogus prekių pristatymas su kurjeriu 1-2 d.d.

Pristatysime į namus Antradienį, Kovo 4 d.

Užsakymus nuo 29 € pristatome nemokamai! Iki nemokamo pristatymo trūksta: 24,81 €

* Dėmesio: pristatymo terminai yra preliminarūs ir gali priklausyti nuo kurjerių užimtumo.

Likučiai parduotuvėse

Visada galite užsukti į artimiausią mūsų parduotuvę ir įsigyti norimas prekes. Likučių duomenys atnaujinti prieš 1 val. 40 min.

Apie prekę

Indikacijos: šunims gydyti, esant mišriam užsikrėtimui suaugusių nematodų ir cestodų rūšimis.

Kontraindikacijos: negalima naudoti mažiau kaip 5 kg sveriantiems šunims. Negalima naudoti esant žinomam padidėjusiam jautrumui veikliosioms medžiagoms ar bet kuriai iš pagalbinių medžiagų. 

Dozės ir naudojimo būdas

Mažiausia rekomenduotina dozė: 0,5 mg milbemicino oksimo ir 5 mg prazikvantelio 1 kg kūno svorio, sušerti per kartą. Veterinarinį vaistą reikia duoti su pašaru arba gyvūnui šiek tiek paėdus.

Praktinės dozavimo rekomendacijos, atsižvelgiant į šuns kūno svorį:

  • 5–25 kg - 1 tabletė
  • > 25–50 kg - 2 tabletės
  • > 50–75 kg - 3 tabletės 

Vaistą galima naudoti veisiamiems šunims, įskaitant šuningas ir laktuojančias kales.

Specialios atsargumo priemonės: jaunesnius kaip 4 savaičių amžiaus gyvūnus gydyti šiuo veikliųjų medžiagų deriniu netikslinga. Vaistą naudoti kartu su kitais makrocikliniais laktonais reikia atsargiai.

Pranešimas apie šalutinį poveikį

Jeigu įtariate, kad šiuo veterinariniu vaistu gydytam gyvūnui atsirado nepageidaujamų šalutinių reiškinių, apie šalutinį poveikį galite pranešti Valstybinei maisto ir veterinarijos tarnybai, užpildydami interneto svetainėje https://vmvt.lt/gyvunu-sveikata-ir-gerove/gyvunu-sveikata/veterinariniai-vaistai-ir-biocidai/farmakologinis-budrumas esančią formą ir pateikdami ją tarnybai svetainėje nurodytu el. paštu.

Atsisiuntimai

Skirta

Antiparazitinės priemonės paskirtis
Nuo parazitų
Antiparazitinės priemonės forma
Tabletės

Sudėtis

(1 tabletė)
veikliosios medžiagos
milbemicino oksimas 12,5 mg
prazikvantelis 125,0 mg

Lorem ipsum dolor sit amet, consectetur adipiscing elit